Next Article in Journal
An Improved Method for Extracting Rat Cerebrospinal Fluid with Repeatable Large-Scale Collection
Previous Article in Journal
Equine Herpesvirus-1 Induced Respiratory Disease in Dezhou Donkey Foals: Case Study from China, 2024
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Biological Characteristics and Whole-Genome Analysis of a Porcine E. coli Phage

1
College of Animal Science and Technology, Shihezi University, Shihezi 832003, China
2
Xinjiang Tecon Animal Husbandry Technology Co., Ltd., Changji 831399, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Vet. Sci. 2025, 12(1), 57; https://doi.org/10.3390/vetsci12010057
Submission received: 13 December 2024 / Revised: 9 January 2025 / Accepted: 12 January 2025 / Published: 14 January 2025

Simple Summary

In this study, we aimed to investigate the characteristics of bacteriophages that are capable of lysing multidrug-resistant Escherichia coli derived from pigs, providing a reference for phage therapy. Phages obtained from fecal waste were isolated and purified, and their morphology was observed using transmission electron microscopy. Their biological characteristics were identified and whole-genome sequencing analysis was performed. A bacteriophage of Siphaviridae, which lyses porcine E. coli, was isolated and named vB_EcoS_Psq-1 (Psq-1). It has a narrow lytic range but possesses stable biological properties. The genome of Psq-1 is dsDNA, which possesses a length of 44,183 bp and a GC content of 52.16%. It does not contain known resistance, lysogenic, or virulence genes and has 55 open reading frames (ORFs). Psq-1 exerted a significant inhibitory effect on E. coli during in vitro antibacterial experiments. Psq-1 can serve as a reference isolate, aiding in the study of bacteriophages that can be used to treat multidrug-resistant porcine E. coli.

Abstract

(1) Background: In recent years, the increasing emergence of multidrug-resistant pathogens in pig farms has begun to pose a severe threat to animal welfare and, by extension, public health. In this study, we aimed to explore the biological characteristics and genomic features of bacteriophages that are capable of lysing porcine multidrug-resistant E. coli, which was isolated from sewage. In doing so, we provided a reference for phage therapies that can be used to treat multidrug-resistant strains. (2) Method: Using the multidrug-resistant E. coli isolate sq-1 as the host bacterium, bacteriophages were isolated and purified from fecal samples using a double-layer agar plate method. The morphology was observed using a transmission electron microscope, and its host range, optimal multiplicity of infection (MOI), one-step growth curve, thermal stability, acid–base tolerance, and in vitro antibacterial ability were tested. Genomic features were analyzed using whole-genome sequencing. (3) Results: A lytic phage named vB_EcoS_Psq-1 (abbreviated as Psq-1) was successfully isolated. Electron microscopy revealed that Psq-1 belongs to the family of long-tailed phages, possessing clear and transparent plaques of approximately 1 mm in diameter. Psq-1 only lyses the host bacterium and does not affect other E. coli strains or other species of bacteria. The optimal MOI for phage Psq-1 was 0.1, with a latent period of 25 min, an exponential growth period of 25 min, and a lysis yield of 44.21 PFU/cell. Its activity remains stable at temperatures between 40 °C and 60 °C and from pH 4.0 to pH 13.0. Psq-1 exhibited a significant inhibitory effect on E. coli in liquid culture medium. The nucleic acid type of phage Psq-1 was dsDNA, with a total genome length of 44,183 bp and a GC content of 52.16%. No known resistance, lysogenic, or virulence-related genes were detected. The whole genome contains 55 open reading frames (ORFs). (4) Conclusions: This study isolated a bacteriophage that is capable of lysing multidrug-resistant E. coli. Characterized by a narrow E. coli lysis range, a long latent period, limited lytic ability, and stable biological properties, this bacteriophage can serve as a reference isolate for E. coli phages and can provide biological materials and data to support research on bacteriophages that are effective against multidrug-resistant porcine E. coli.

1. Introduction

Escherichia coli, which belongs to the family Enterobacteriaceae and the genus Escherichia and is widely distributed in the intestines of both humans and animals, is the most common type of Gram-negative bacteria. As a result of environmental changes, some strains of E. coli gradually acquire certain virulence factors [1] and become pathogenic. These bacteria can be categorized as enteropathogenic or extraintestinal pathogenic E. coli. Such bacteria pose significant problems for the swine-farming industry, inducing edema, neonatal diarrhea, and white diarrhea in piglets, leading to high mortality rates. These illnesses not only affect the animals’ growth and development but also result in significant economic losses for pig-farming operations [2]. As the world’s largest producer and consumer of pork, our country has historically used significant quantities of antibiotics to prevent and control bacterial diseases within pig farms. Unfortunately, reports indicate that the widespread use of antibiotics over an extended period has accelerated the emergence and spread of antibiotic-resistant strains [3,4]. The widespread prevalence of multidrug-resistant bacterial strains has significantly reduced the effectiveness of antibiotics [5], and, thus, the search for safe and efficient treatment strategies to address antibiotic-resistant bacterial infections in animal husbandry is becoming increasingly urgent.
Phages—viruses that specifically infect and lyse bacteria—have widespread prevalence in water, soil, air, and feces [6]. They possess high host specificity, stable safety, and effectiveness in controlling antibiotic-resistant bacteria [7]. As such, they are viewed as a highly promising means of treating bacterial infections in the postantibiotic era. Phages have widespread applicability to various tasks, including disease treatment, food preservation, control of plant pathogens, vaccine development, delivery systems, management of bacterial biofilms, and surface disinfection [8]. D’Herelle [9] was the first researcher to test phage therapy in animals, successfully treating fowl typhoid in chickens—the survival rate of birds receiving the phage treatment was 95–100%, while the untreated control group had a survival rate of 0–25%. Meanwhile, in their work, Atterbury and colleagues [10] selected three lytic phages that had a broad host range against Salmonella enteritidis, Citrobacter rodentium, and Salmonella typhimurium. They demonstrated good preventive effects in 36-day-old Ross broilers. In our study, we isolated a lytic phage from multidrug-resistant E. coli derived from pigs and analyzed its biological and genomic characteristics. Through whole-genome sequencing, it is possible to compare the genes of phages with a broad lytic spectrum to those with a narrow lytic spectrum. This can help to identify the reasons for the differences in phages’ lytic ranges, providing a theoretical basis and data to support future phage therapies with an expanded host range.

2. Materials and Methods

2.1. Strain and Sample Collection

The multidrug-resistant E. coli strain sq-1 and other tested strains (30 strains of E. coli, 21 strains of Klebsiella pneumoniae, and two strains of Proteus vulgaris) were isolated and identified by the Animal Infectious Disease Laboratory at Shihezi University. In preliminary tests, the exponential growth phase of the E. coli strain sq-1 exhibited resistance to eight antibacterial agents: β-lactam antibiotics, including penicillin G, amoxicillin, and ampicillin; chloramphenicol-class antibiotics such as florfenicol; sulfonamides such as trimethoprim–sulfamethoxazole; tetracyclines such as oxytetracycline; fluoroquinolones, including enrofloxacin; and glycopeptides such as vancomycin. This bacterium is classified as a multidrug-resistant strain (unpublished data).
Feces and wastewater were collected from large-scale pig farms in the Ili region of Xinjiang and underwent subsequent phage isolation.

2.2. Main Reagents and Instruments

Luria–Bertani medium (Cat: HB0128) was purchased from Hopebio Co., Ltd. (Qingdao, China); agar powder (Cat: A8190), 2% Phosphotungstic acid negative staining solution (Cat: G1870), and PEG8000 (Cat: P8260) were obtained from Beijing Solarbio Science & Technology Co., Ltd. (Beijing, China). The antimicrobial disks were obtained from Hangzhou Binhao Microbial Reagent Co., Ltd. (Hangzhou, China), and the viral DNA/RNA extraction kits (Cat: S50622) were acquired from TransGen Biotech (Beijing, China).
The Pico17 centrifuge was purchased from Thermo-Fisher Scientific (Shanghai) Instruments Co., Ltd. (Shanghai, China), the BMJ-160 vertical constant-temperature incubator was obtained from American Genius (Suzhou) Co., Ltd. (Suzhou, China), and the HHW21.600ALL intelligent electric constant-temperature water bath was acquired from the Beijing Yongguangming Medical Instrument Factory (Beijing, China). The HT7700 transmission electron microscope was obtained from Hitachi High-Technologies Corporation (Tokyo, Japan). The IS-RDV1 vertical double-layer constant-temperature shaker was purchased from American Genius Co., Ltd. (Suzhou, China).

2.3. Enrichment of Phages

Phage enrichment was carried out as described by Nikkhahi et al. [11], with slight modifications. A culture of the log period E. coli strain sq-1 was used as the host bacterium, inoculated into LB liquid medium, and incubated overnight at 37 °C with shaking at 180 r/min. Samples of feces and wastewater collected from pig farms were mixed and soaked in SM buffer overnight for phage enrichment purposes. The following day, the mixture was filtered through gauze to remove any debris. A total of 40 mL of the filtered fecal suspension and 1 mL of the enriched E. coli culture were added to 300 mL of LB liquid medium, which was then incubated at 37 °C with shaking at 180 r/min for 12 h. The culture was centrifuged at 12,000 r/min for 15 min at 4 °C, and the supernatant was collected and filtered through a 0.22 μm filter for sterilization. The resulting filtrate was designated as the phage stock solution and was stored at 4 °C for future use.

2.4. Isolation and Purification of Phages

Chang HC et al. [12] employed a drop-by-drop technique to determine whether the phage stock solution contained lytic phages. A 100 μL log period E. coli culture was inoculated onto LB solid medium and evenly spread using an inoculation loop. After the culture was absorbed, 5 μL of the phage stock solution was added dropwise onto LB solid medium, which was then incubated at 37 °C for 8–12 h, after which the formation of lysis plaques was observed.
Using a sterile pipette tip, a single clear plaque was selected and placed in 200 μL of SM buffer solution, followed by incubation at 4 °C overnight. Afterward, the liquid was collected and added to 100 μL of host bacteria in LB broth, incubated, and shaken for 5–8 h. The culture was removed and centrifuged at 12,000 r/min for 15 min at 4 °C, and then 100 μL of the supernatant and 100 μL of the host bacteria were transferred into a test tube. Phages were purified using the double-layer agar plate method, and the purification process was repeated 3–5 times until uniform lytic plaques of similar size and shape appeared on the plates.

2.5. Concentration of Phages and Observation by Electron Microscopy

Referring to the methods of Hou Gongmingzhu et al. [13], a slight adjustment was made to the polyethylene glycol (PEG) precipitation technique used for concentrating purified phages. An appropriate amount of PEG8000 (to a final concentration of 10%) was added to the prepared phage solution and stirred until dissolved, and the solution was placed in an ice bath for 20–24 h to allow the phage particles to fully precipitate. All liquid was transferred to a 50 mL centrifuge tube and centrifuged at 4 °C at 8000 r/min for 10 min, and the supernatant was discarded. The phage pellet was resuspended in SM buffer and allowed to stand at 4 °C for 1 h. Subsequently, an equal volume of chloroform was added to extract PEG and cell debris from the phage solution. The mixture was centrifuged at 4 °C and 3000 r/min for 15 min to recover the hydrophilic phase containing the phage particles, yielding a concentrated phage solution.
The phage concentrate (50 μL) was added to the copper grid and allowed to adsorb for 10 min. Next, 2% phosphotungstic acid staining was implemented for 5 min, followed by removal of the copper grid. The sample was irradiated with infrared light for 30 min, and the phage morphology was observed using a transmission electron microscope.

2.6. Study of the Biological Characteristics of Phages

2.6.1. Determination of Phage Lysis Profile

Using the drop method, the lytic range of the isolated bacteriophages against 30 strains of E. coli, 21 strains of Klebsiella pneumoniae, and two strains of Proteus vulgaris, excluding the host strain sq-1, was determined. Firstly, 200 µL of fresh bacterial solution was collected during the exponential growth phase (OD600 = 0.6) and evenly coated on LB solid medium. After drying, 5 μL of the bacteriophage (108 PFU/mL) suspension was added to the inoculated area, and the plates were incubated at 37 °C overnight. The formation of plaques was observed; if plaques appeared while the control area showed normal bacterial growth, it indicated that the bacteriophage lysed the bacterial strain.

2.6.2. Optimal Multiplicity of Infection and One-Step Growth Curve

To determine the optimal multiplicity of infection (MOI) of the bacteriophages, we utilized the method described by Li et al. [14], with slight modifications. The host bacteria were cultured to the logarithmic growth phase (OD600 = 0.6, about 108 CFU/mL) and mixed with various MOIs (100, 10, 1, 0.1, 0.01, 0.001) in quantities of 100 μL each. Following the addition of 800 μL LB liquid medium, the mixture was incubated at 37 °C with shaking at 180 rpm for 4 h. After centrifugation at 12,000 r/min for 10 min, the supernatant was filtered through a 0.22 μm membrane to remove unlysed bacteria. The bacteriophage titer in the different treatment groups was assessed using the double-layer agar plate method, and the results were observed and counted after 12 h. The experiment was repeated thrice, and the average was calculated.
To determine the one-step growth curve of the bacteriophages, we utilized the method described by Hou Gongmingzhu et al. [13], with some adjustments. The bacteriophage solution was mixed in equal volumes with E. coli in the logarithmic growth phase at the optimal multiplicity of infection (MOI) ratio and incubated at 37 °C for 10 min for adsorption. The mixture was centrifuged at 12,000 r/min for 10 min, and the supernatant was discarded. After that, the pellet was resuspended in 20 mL LB liquid medium and incubated in a shaking incubator at 37 °C and 180 rpm. Five milliliters of the culture was collected at different time points (0, 5, 10, 15, 20, 25, 30, 40, 50, 60, 80, 100, 120, 150, and 180 min) and centrifuged at 12,000 r/min for 5 min, and the supernatant was used to determine the bacteriophage titer via the double-layer agar plate method. The experiments were repeated thrice, and the average value was calculated.

2.6.3. Thermostability and pH Sensitivity

Two milliliters of phage solution was placed in a constant-temperature water bath at different temperatures (40 °C, 50 °C, 60 °C, 70 °C, and 80 °C). Samples of 200 μL were taken at incubation times of 20, 40, and 60 min. The phage titer was determined using the double-layer agar plate method. The experiment was repeated thrice, and the average values were calculated.
The phage solution (100 μL) was mixed with 900 μL of LB liquid culture media at different pH values (1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, 11.0, 12.0, and 13.0) and incubated in a 37 °C water bath for 2 h. After incubation, the phage titer was assessed using the double-layer agar plate method. The experiment was repeated three times, and the average value was calculated.

2.7. In Vitro Phage Inhibition Test

An in vitro phage inhibition test was conducted as described by Han et al. [15]. A single colony of the host bacterium sq-1 was inoculated on 5 mL LB medium and incubated to OD600 = 0.2, and phages were added at MOI = 10, 1, and 0.1. The mixture was incubated at 37 °C with shaking at 180 r/min in an oscillating incubator for 12 h. Phage-free E. coli sq-1 culture medium was used as the control. The absorbance (OD600) was measured every 1 h during the culture using a full-wavelength enzymograph. The experiment was repeated three times, and the average value was calculated.

2.8. Sequencing and Bioinformatics Analysis of Phage Genome

The phage genome was extracted according to the instructions of the viral DNA/RNA extraction kit, and the product was sent to Hangzhou Huitong Biotechnology Co., Ltd. (Hangzhou, China), for sequencing. The whole genome was sequenced using the Illumina NovaSeq 6000 sequencing platform, with the TruSeq RNA library preparation method and paired-end sequencing mode, and Newbler software (Version: 2.9.0) was utilized for sequence assembly. GeneMarkS software (Version: 4.6b, https://exon.gatech.edu/genemarks.cgi, accessed on 3 December 2023) was used to predict the gene sequences. The Antibiotic Resistance Gene Database (CARD) (https://card.mcmaster.ca, accessed on 3 December 2023) was used to predict the phage genome of antibiotic resistance genes, and online software (http://www.genomicepidemiology.org/services/, accessed on 7 October 2024) was utilized to ascertain the virulence factors of phage genome genes. The online software CGView Server (https://js.cgview.ca, accessed on 1 October 2024) was used to map the entire phage genome. The terminal large subunit protein, endolysin, and long-tail fibrin of the phages were used for phylogenetic tree analysis. The sequences of the terminal large subunit protein, endolysin, and long-tail fibrin of the phage were compared using the NCBI website, and the phylogenetic tree was drawn using MEGA 7.0. Finally, we used the online tool ESPript 3.0 (https://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi, accessed on 31 December 2024) to compare the amino acid sequences of the phage long-tail fibrin proteins.

2.9. Statistical Analysis

All statistical analyses were performed using GraphPad Prism 9.0. The significance of the experimental data was assessed via multiple t-tests. The error bars represent the standard deviation (SD) of the mean.

3. Results

3.1. Isolation and Purification of Phage and Morphological Observation Under an Electron Microscope

The multidrug-resistant E. coli strain sq-1 was used as a host bacterium to successfully isolate a lytic E. coli phage from mixed samples of sewage and feces. According to the standards of the International Committee on Taxonomy of Viruses (ICTV) [16], the bacteriophage was named vB_EcoS_Psq-1 (Psq-1). It has neat and clear edges, with a diameter of approximately 1 mm, and no halo (Figure 1A). Transmission electron microscopy (TEM) revealed that Phage Psq-1 has a regular icosahedral head with a diameter of 76.60 nm and a tail of 127.66 nm in length. It conforms to the morphological characteristics of the order Caudovirales and the family Siphoviridae (Figure 1B).

3.2. Biological Characteristics of Phage Psq-1

3.2.1. Host Range of Phage Psq-1

The bacteriophage Psq-1 can lyse the host bacterium sq-1; however, it is incapable of lysing the other E. coli, Klebsiella pneumoniae, and Proteus mirabilis from pigs.

3.2.2. Optimal Multiplicity of Infection and One-Step Growth Curve of Phage Psq-1

At a MOI of 0.1, phage Psq-1 had the highest titer of approximately 1.74 × 109 PFU/mL (Figure 2A). The optimum MOI for this phage is 0.1.
The one-step growth curve showed that the latency period of Psq-1 was approximately 25 min, and the titer of Psq-1 increased rapidly within a 25–40 min period. Within 40–70 min, the phage titer slowly increased until the 70 min mark, at which point it stabilized, reaching 8.444 log PFU/mL (Figure 2B). The burst period of the phage was 15 min, and the cleavage volume was 44.21 PFU/cell.

3.2.3. Thermostability and pH Sensitivity of Phage Psq-1

Phage Psq-1 was incubated at 40 °C, 50 °C, and 60 °C for 60 min, and the titer remained consistent. After incubation at 70 °C and 80 °C for 20 min, the phage titer decreased slightly; after 40 min of incubation, all phage activity ceased (Figure 2C).
At a pH of 4.0~13.0, the phage maintained high activity, whereas at pH 6.0 and 12.0, the phage titer decreased slightly. Finally, at pH ≤ 3.0 and pH ≥ 14.0, the phages were completely inactive (Figure 2D).

3.3. In Vitro Phage Psq-1 Inhibition Test

In the control group, to which no phage was added, E. coli Sq-1 continued to grow during the 12-h culture period. However, when phages at MOI = 10, 1, and 0.1 were added to the medium, phage Psq-1 significantly inhibited the growth of E. coli Sq-1 during the first 0 to 6 h. The OD values of the control group consistently increased, while the OD values of the test groups with phages exhibited no significant changes. Between 6 and 12 h, the OD values in the test groups continued to increase but remained below the OD values of the control group, indicating that phage Psq-1 can inhibit the growth of E. coli in vitro (Figure 3).

3.4. Whole-Genomic Analysis of Phage Psq-1

Whole-genome sequencing was performed, and the average sequencing depth was 17620X. The nucleic acid type of Psq-1 (GenBank accession: PQ595991) was double-stranded DNA (dsDNA), the total length of the genome was 44 183 bp, the GC content was 52.16%, and the AT content was 47.84%. CARD and the VirulenceFinder 2.0 database were compared, revealing that Phage Psq-1 did not carry known resistance or virulence genes.
According to bioinformatics analysis, there were 55 open reading frames (ORFs) in the whole genome of phage Psq-1, of which 34 were forward-coded and 21 were reverse-coded. Of these, 26 ORFs encoded known functional proteins, 29 were hypothesized protein sequences, and one was an unknown functional protein sequence (Table 1). The known functional proteins of phages can be divided into four functional blocks: structural and packaging genes, genes related to DNA replication and regulation, genes related to metabolism, and genes related to cleavage. The online tool CGview (https://js.cgview.ca; accessed on 3 December 2023) was used to visualize the phage whole-genome map. The outer open CDSs are painted in blue (phage structure and packaging proteins), red (lysis-related proteins), orange (DNA replication- and regulation-related proteins), and purple (metabolic-related proteins); triangular arrows indicate different functional module genes (Figure 4). Whole-genome analysis revealed that ORF3, ORF4, and ORF5 control the synthesis of proteins associated with bacteriophage lysis of bacteria. ORF3 and ORF4 are holin-like class II proteins, also known as perforin, which are similar to the holin proteins in bacteria. Perforins are a class of proteins that participate in bacteriophages’ infection of bacteria by forming holes in the bacterial cell membrane, helping the bacteriophage to release its genetic material into the bacterial cell interior. ORF5 encodes lysozyme, which can destroy mucopolysaccharides in the bacterial cell wall, causing the cell wall to rupture and, ultimately, leading to bacterial lysis. A phylogenetic tree was constructed with conserved terminal large subunit protein sequences of evolutionary significance (Figure 5), and phage Psq-1 and Escherichia phage PaulFeyerabend (GenBank accession: NC_073067.1) were the closest relatives. This suggests that phage Psq-1 belongs to the realm Heunggongvirae, the phylum Uroviricota, the Caudoviricetes class of tailed bacteriophages, and the family Siphoviridae, as a type of dsDNA virus. The phylogenetic tree was constructed using the neighbor-joining method with 1000 bootstrap replicates. The phylogenetic tree constructed using an endolysin protein sequence showed that phage Psq-1 was closely related to Escherichia phage HH3 (GenBank accession: XAM99490.1). The long-tail fibrin of Phage Psq-1 has a distant relationship with the other six types of long-tail fibrin. A comparison between the genome of phage Psq-1 and that of phage pEC-M719-6WT.2 (GenBank accession: OQ845958.1), which has a wide lytic range, revealed that the average similarity of its long-tail fibrin was 6.53%, with an overall similarity of 59.97%.

4. Discussion

Due to the widespread use of antibiotics, multidrug-resistant strains have emerged, posing a serious threat to the pig-farming industry and to human public health [2]. Aiming to reduce the use of antibiotics and explore biological agents for treating diseases caused by E. coli infections in pig farms, we collected sewage samples from large-scale pig farms and successfully isolated a phage Psq-1 that is capable of lysing E. coli strain sq-1. The biological characteristics, genomic features, and genetic background of Psq-1 were preliminarily explored, providing a theoretical basis for further research on phages. The phage Psq-1 isolated in this experiment belongs to the family Siphoviridae and possesses a long latency period and burst phase. A shorter latency period can enable phages to function more quickly and produce a large number of offspring. Phage Psq-1 has strong tolerance to a range of temperatures and pH levels and can survive in most environments. The optimal MOI of phage Psq-1 is consistent with the isolation of phage BP32 in a previous study by Wu et al. [17], but the latency period and burst phase are shorter than those of BP32. The lysis yield of phage Psq-1 is higher than that of vB-EcoC-P17 (17 PFU/cell) [18], but the lysis range of phage P17 is broader. In terms of temperature and pH tolerance, phage Psq-1 is stronger than phage SDYTW1-F1-2-2 and phage IME178 [19,20]. Different phages have different biological characteristics; however, safety is the priority in clinical practice. Phage Psq-1 was compared via CARD and VirulenceFinder2.0, and no known resistance or virulence genes were identified. The host range of this phage is relatively narrow, which may limit its clinical applicability. However, it still has various potential applications in specific environments. For example, in industrial or agricultural settings, where the temperature and pH are relatively stable, Psq-1 may be an effective biological control agent. In addition, its shorter latency period and burst phase indicate that it can respond quickly to bacterial infections and provide rapid therapeutic effects. To expand its applicability, Psq-1 can be combined with other phages to form a phage cocktail [21]. Phages, a type of antibacterial biological agent, are characterized by their specific and efficient lysis of host bacteria, safety, low cost, and abundant sources. Continuously enriching the phage library and comparing the differences between different phages facilitates the modification of alternative antibiotic biological agents with a wide lysis range and high lysis efficiency [22]. This not only expands the host range but also reduces the risk of bacterial resistance. Further genetic engineering modifications may enhance the characteristics and safety of Psq-1. Isolating and characterizing Psq-1 provides valuable information for the development of novel antibacterial strategies. In future, researchers should focus on evaluating its in vivo activity, safety, and synergistic effects with other treatment methods, which will inform its application in clinical practice.
Some research indicates [23] that, when exploring the antibacterial effects of bacteriophages in liquid environments, bacterial concentrations tend to rise in the later stages of inhibition, leading to a decrease in the bacteriophages’ effectiveness. In this study, we assessed the in vitro antibacterial effect of the E. coli phage Psq-1 and revealed that Psq-1 exhibits its strongest antibacterial effect against E. coli sq-1 within the first 6 h. This duration is notably shorter compared to the prolonged optimal antibacterial effect observed for the phages isolated by Liao Binru et al. [24]. During the experiment, we noted that, after a certain period, the bacterial concentration rebounded, indicating a decline in antibacterial efficacy. This finding is consistent with results reported by Rong Ruiyao [25], Man Cheng [26], and Chen Liying [27]. It can be inferred that E. coli sq-1 may be resistant to phage Psq-1, and, thus, the inhibitory effect of the phage decreased. When the MO = 10, the inhibitory effect of the bacteriophage is stronger compared to that observed at MOI values of 1, 0.1, and 0.01. Thus, using a higher MOI in clinical treatment may yield better therapeutic outcomes for this bacteriophage.
In this study, we predicted multiple important functional genes in the Psq-1 phage genome, including ORF3, ORF4, and ORF5, which are important lytic proteins of the phage, and holin, a membrane protein that can regulate the length of the infection cycle to ensure optimal lysis. Lysozyme acts as a lytic protein by degrading peptidoglycan in the bacterial cell walls and disrupting bacterial membranes [28]. At present, in addition to studying the biological characteristics of phages, researchers are expressing an increasing interest in the special protein lyases and depolymerases encoded by bacteriophages. Exploring the use of these two enzymes and their antibacterial effects when combined with other drugs is a current research hotspot [29]. ORF32 is a phage-long-tail fibrin that can bind to host surface receptor proteins, thereby initiating bacterial lysis [30]. Most regions of the long-tail fibrin of phages are relatively conserved, so different phages can change the size of their host range through the recombination of long-tail fibrin sequences [31]. This may also contribute to the relatively small host range of the Psq-1 phage. Whole-genome sequencing of this phage can be compared with other spectral phage sequences to determine the factors that control the phage lysis range, providing good biomaterial for future research on antibacterial biologics.

5. Conclusions

In this study, we isolated the bacteriophage Psq-1, of the Siphoviridae family, from sewage. Psq-1 only lyses host bacteria, leaving other strains of E. coli and other species of bacteria unaffected. The optimal multiplicity of infection (MOI) for phage Psq-1 is 0.1, and it has an incubation period of 25 min, a burst phase of 15 min, and a cleavage volume of 44.21 PFU/cell. Its activity remains stable in environments ranging from 40 to 60 degrees Celsius and pH 4.0 to pH 13.0. In vitro antimicrobial tests revealed that the optical density (OD) value of the bacterial culture added to the phage was consistently lower than that of the phage-free culture, highlighting a significant inhibitory effect. No known resistance, lysogenicity, or virulence-related genes were detected. It can be used as a reference isolate for E. coli phages and a source of biological materials and data support for research on bacteriophage-related treatment of porcine E. coli.

Author Contributions

Writing—original draft preparation, S.W.; conceptualization, N.L.; correction of English grammar, S.H.; investigation, P.Z.; theoretical guidance, Y.L. (Yanfang Li); resources, Y.L. (Yan Liang); supervision, Y.Q.; project administration, Y.Q.; funding acquisition, Y.Q. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Natural Science Support Program Project of the Xinjiang Production and Construction Corps (2024DA007) and the Science and Technology Plan Project of the Xinjiang Production and Construction Corps (2022AA004). The APC was funded by the Natural Science Support Program Project of the Xinjiang Production and Construction Corps (2024DA007).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data and materials are contained in this article.

Acknowledgments

The authors wish to express their gratitude to the College of Animal Science and Technology, Xinjiang Tecon Animal Husbandry Technology Co., Ltd., for facilitating this study. The authors also thank the aforementioned funding bodies for their financial support.

Conflicts of Interest

Pei Zheng is an employee of the Xinjiang Tecon Animal Husbandry Technology Co., Ltd., Changji 831399, China. The other authors have no conflicts of interest to declare.

References

  1. Tang, F.; Wang, J.; Li, D.; Gao, S.; Ren, J.; Ma, L.; Liu, F.; Zhuge, X.; Yan, G.; Lu, Y.; et al. Comparative genomic analysis of 127 Escherichia coli strains isolated from domestic animals with diarrhea in China. BMC Genom. 2019, 20, 212. [Google Scholar] [CrossRef]
  2. Liu, X.S.; Zhang, Y.; Wang, S.; Yang, X.D.; Zhu, X.X.; Chen, X.; Wang, G.Y.; Mu, Y.C.; Luo, T.Y.; Shi, T.R. Detection of virulence genes and drug susceptibility testing of pathogenic Escherichia coli from pigs. Mod. Livest. Technol. 2021, 9, 25–26+28. [Google Scholar]
  3. Yang, H.; Paruch, L.; Chen, X.; van Eerde, A.; Skomedal, H.; Wang, Y.; Liu, D.; Liu Clarke, J. Antibiotic Application and Resistance in Swine Production in China: Current Situation and Future Perspectives. Front Vet. Sci. 2019, 6, 136. [Google Scholar] [CrossRef]
  4. Prestinaci, F.; Pezzotti, P.; Pantosti, A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health 2015, 109, 309–318. [Google Scholar] [CrossRef]
  5. Chang, L.L.; Pei, S.L.; Li, H.K.; Sun, P.; Wang, H.J.; Wang, Y.Y. Serotype investigation and drug resistance detection of Escherichia coli from pigs in Xuzhou area. Anim. Husb. Vet. Med. 2020, 52, 116–120. [Google Scholar]
  6. Wang, B.; Li, Y.; Huang, A.Q.; Liu, L.; Li, Y.B.; Wang, L. Research progress on bacteriophage control of foodborne pathogens in food. Food Res. Dev. 2024, 45, 204–209. [Google Scholar]
  7. Reardon, S. Phage therapy gets revitalized. Nature 2014, 510, 15–16. [Google Scholar] [CrossRef]
  8. Harada, L.K.; Silva, E.C.; Campos, W.F.; Del Fiol, F.S.; Vila, M.; Dąbrowska, K.; Krylov, V.N.; Balcão, V.M. Biotechnological applications of bacteriophages: State of the art. Microbiol. Res. 2018, 212–213, 38–58. [Google Scholar] [CrossRef]
  9. D’Herelle, F. Sur le role du microbe bacteriophage dans la typhose aviare. C. R. Acad. Sci. 1919, 169, 932–934. [Google Scholar]
  10. Fiorentin, L.; Vieira, N.D.; Barioni, W., Jr. Oral treatment with bacteriophages reduces the concentration of Salmonella Enteritidis PT4 in caecal contents of broilers. Avian Pathol. 2005, 34, 258–263. [Google Scholar] [CrossRef]
  11. Nikkhahi, F.; Dallal, M.M.S.; Alimohammadi, M.; Foroushani, A.R.; Rajabi, Z.; Fardsanei, F.; Imeni, S.M.; Bonab, P.T. Phage therapy: Assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice. Gastroenterol. Hepatol Bed Bench 2017, 10, 131–136. [Google Scholar]
  12. Chang, H.C.; Chen, C.R.; Lin, J.W.; Shen, G.H.; Chang, K.M.; Tseng, Y.H.; Weng, S.F. Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5. Appl. Environ. Microbiol. 2005, 71, 1387–1393. [Google Scholar] [CrossRef]
  13. Hougong, M.Z.; Zhou, H.Q.; Yu, X.Y.; Li, N.N.; Li, Y.; Qu, Y.G.; Li, Y.F.; Liang, Y.; Yan, D.; Yang, S.H.; et al. Biological characteristics and whole genome analysis of a sheep derived multidrug-resistant Klebsiella pneumoniae bacteriophage Chinese. Anim. Husb. Vet. Med. 2024, 51, 2047–2057. [Google Scholar]
  14. Li, F.; Xing, S.; Fu, K.; Zhao, S.; Liu, J.; Tong, Y.; Zhou, L. Genomic and biological characterization of the Vibrio alginolyticus-infecting “Podoviridae” bacteriophage, vB_ValP_IME271. Virus Genes 2019, 55, 218–226. [Google Scholar]
  15. Han, P.; Pu, M.; Li, Y.; Fan, H.; Tong, Y. Characterization of bacteriophage BUCT631 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae. Virol. Sin. 2023, 38, 801–812. [Google Scholar] [CrossRef]
  16. ICTV. “Taxonomy of Viruses: 2023 Update”. International Committee on Taxonomy of Viruses. 2023. Available online: https://www.ictvonline.org/taxonomy/past-reports/2023-report/ (accessed on 10 October 2024).
  17. Wu, J.N.; Li, Z.H.; Li, F.X.; Zhang, Z.X.; Zhang, Y.F.; Song, J.L. Isolation, identification, and biological characteristics analysis of a multidrug-resistant Escherichia coli bacteriophage BP32 Chinese. Anim. Husb. Vet. Med. 2024, 51, 3540–3551. [Google Scholar]
  18. Chang, J.S.; Yang, R.Y.; Dai, X.Z.; Qu, Y.G.; Liang, Y.; Li, N.; Zhao, Y.; Wang, Z.Y.; Zhang, X.Y. Isolation and biological characteristics analysis of Escherichia coli bacteriophages from bovine mastitis source. Prog. Vet. Med. 2022, 43, 25–29. [Google Scholar]
  19. Jia, X.C.; Xiao, T.S.; Zhu, X.L.; Hao, Z.H. Isolation, identification, and whole genome analysis of a lytic colistin resistant Escherichia coli bacteriophage. J. China Agric. Univ. 2024, 29, 131–140. [Google Scholar]
  20. Li, F.; Li, L.; Na, S.; Zhao, J.; Liu, F.; Liu, P.; Li, Y.; Li, M.; Lei, M.; Zhang, D.; et al. Isolation, characterization, and genomic analysis of a novel phage IME178 with lytic activity against Escherichia coli. Microb. Pathog. 2023, 179, 106099. [Google Scholar]
  21. Li, S.Y.; Zhao, T.T.; Chen, Y.X.; Liu, H.J. In front of the Chai family Phage therapy and its application in livestock and poultry breeding processes Shandong. Anim. Husb. Vet. Med. 2024, 45, 87–89. [Google Scholar]
  22. Zhao, Y.H. Isolation and Identification of Multidrug Resistant Escherichia coli Bacteriophages and Study on Cocktail Therapy. M.D Thesis, Yangzhou University, Yangzhou, China, 2023. [Google Scholar]
  23. Zhou, Y.Q.; Ma, D.X.; Wu, J.; Wang, X.Y. Isolation, Identification and Characterization of Broad-Spectrum Escherichia coli O157:H7 CVCC4050 Bacteriophage vB_EcoM_GXBP08. China Anim. Husb. Vet. Med. 2022, 49, 2735–2745. [Google Scholar]
  24. Liao, B.; Yu, C.Y.; Huang, Q.C.; Mo, Y.P.; Huang, W.Q.; Li, L.; Han, K.O.; Wang, L.P.; Li, X.; Wang, X.Y. Isolation, identification and characterization of a strain of Salmonella bacteriophage. China Anim. Husb. Vet. Med. 2023, 50, 4168–4178. [Google Scholar]
  25. Rong, R.F.; Guo, H.Y.; Hu, P.C.; Zuo, J.H.; Zhang, D.C.; Guo, Z.L.; Li, Y.; Zhang, Y.X.; Wang, X.R.; Zhao, R.; et al. Biological characteristics and genome-wide analysis of a strain of Klebsiella pneumoniae phage KP6. China Anim. Husb. Vet. Med. 2024, 51, 3990–4001. [Google Scholar]
  26. Man, C.; Xu, S.J.; Yuan, H.X.; Zhao, H.L.; Liu, W.B.; Zou, L.; Yi, Y.B.; Zhang, C. Biological characteristics and genome-wide sequence analysis of a canine Ackermannviridae bacteriophage LHE287. Chin. J. Biotechnol. 2024, 44, 27–35. [Google Scholar]
  27. Chen, L.Y.; Peng, Y.T.; Yan, H.Y.; Chen, P.F.; Xin, A.G.; Li, K. Evaluation of the control effect of virulent bacteriophage KM104 on Salmonella from chickens with different serotypes. China Anim. Husb. Vet. Med. 2024, 51, 278–291. [Google Scholar]
  28. Mukai, F.; Streisinger, G.; Miller, B. The mechanism of lysis in phage T4-infected cells. Virology 1967, 33, 398–404. [Google Scholar] [CrossRef]
  29. Linden, S.B.; Alreja, A.B.; Nelson, D.C. Application of bacteriophage-derived endolysins to combat streptococcal disease: Current state and perspectives. Curr. Opin. Biotechnol. 2021, 68, 213–220. [Google Scholar] [CrossRef]
  30. Chen, P.; Sun, H.; Ren, H.; Liu, W.; Li, G.; Zhang, C. LamB, OmpC, and the Core Lipopolysaccharide of Escherichia coli K-12 Function as Receptors of Bacteriophage Bp7. J. Virol. 2020, 94, e00325-e20. [Google Scholar] [CrossRef]
  31. Mahichi, F.; Synnott, A.J.; Yamamichi, K.; Osada, T.; Tanji, Y. Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity. FEMS Microbiol. Lett. 2009, 295, 211–217. [Google Scholar] [CrossRef]
Figure 1. Morphological characteristics of phage Psq-1: (A) plaque morphology of phage Psq-1; (B) transmission electron microscope morphology of phage Psq-1 (50,000×).
Figure 1. Morphological characteristics of phage Psq-1: (A) plaque morphology of phage Psq-1; (B) transmission electron microscope morphology of phage Psq-1 (50,000×).
Vetsci 12 00057 g001
Figure 2. Biological characteristics of phage Psq-1: (A) determination of optimal multiplicity of infection (MOI) of phage Psq-1; (B) one-step growth curve of phage Psq-1 (50,000×); (C) thermal stability of phage Psq-1; (D) stability of phage Psq-1 at different pH values.
Figure 2. Biological characteristics of phage Psq-1: (A) determination of optimal multiplicity of infection (MOI) of phage Psq-1; (B) one-step growth curve of phage Psq-1 (50,000×); (C) thermal stability of phage Psq-1; (D) stability of phage Psq-1 at different pH values.
Vetsci 12 00057 g002
Figure 3. Phage Psq-1 in vitro inhibition assay (*: p < 0.05).
Figure 3. Phage Psq-1 in vitro inhibition assay (*: p < 0.05).
Vetsci 12 00057 g003
Figure 4. Whole-genome map of Phage Psq-1.
Figure 4. Whole-genome map of Phage Psq-1.
Vetsci 12 00057 g004
Figure 5. (A) Phylogenetic tree composed of terminal large subunits; (B) phylogenetic tree composed of endolysin; (C) phylogenetic tree composed of long-tail fibrin; (D) amino acid comparison of phage long tail fibrin.
Figure 5. (A) Phylogenetic tree composed of terminal large subunits; (B) phylogenetic tree composed of endolysin; (C) phylogenetic tree composed of long-tail fibrin; (D) amino acid comparison of phage long tail fibrin.
Vetsci 12 00057 g005
Table 1. Phage Psq-1 gene prediction and functional annotation.
Table 1. Phage Psq-1 gene prediction and functional annotation.
Functional ModuleORFFunctionIdentity/%E ValueAccession Number
Lysis3holin-like class II protein98.28%2.00 × 10−139NC_073088.1
4holin-like class I protein97.55%1.00 × 10−112NC_016566.1
5lysozyme95.53%0NC_016566.1
Structural and packaging9terminase100.00%7.00 × 10−138YP_004957437.1
10terminase large subunit93.58%0NC_024783.1
11minor tail protein99.80%0YP_010741994.1
16major head protein99.73%0YP_008550148.1
19tail protein94.94%0NC_024783.1
21major tail protein97.52%0NC_073088.1
25minor tail protein98.49%8.00 × 10−143YP_010741450.1
26minor tail protein99.24%0YP_009291470.1
27tail assembly protein98.37%0YP_009288147.1
28tail assembly protein99.02%1.00 × 10−144YP_010742501.1
29tail fiber tip protein98.52%0YP_010742348.1
DNA replication and regulatory24tail-length tape-measure protein99.09%0YP_004957454.1
37DNA methylase97.52%9.00 × 10−115YP_010741570.1
38DNA ligase81.58%8.00 × 10−81YP_009055311.1
40DNA cytosine methyltransferase99.57%5.00 × 10−171YP_010741369.1
41helicase99.37%0YP_010742490.1
43holiday junction resolvase100.00%5.00 × 10−59XDN94337.1
44DNA polymerase99.08%0YP_002720046.1
48exonuclease97.69%0YP_010741426.1
52DNA recombination nuclease inhibitor gamma100.00%4.00 × 10−72YP_010741422.1
53helicase-primase99.20%0WRQ05368.1
Metabolism7DNA repair exonuclease98.68%0.00 × 100 WYA83814.1
39HNH endonuclease protein98.13%4.00 × 10−72YP_010741962.1
Unknown functional protein12head morphogenesis protein96.74%0NC_016566.1
Hypothetical protein1hypothetical protein91.19%0NC_073067.1
2hypothetical protein97.25%4.00 × 10−153ON548431.1
6hypothetical protein98.26%0NC_019724.1
8hypothetical protein98.12%2.00 × 10−98LN881730.1
13hypothetical protein97.87%1.00 × 10−157NC_019419.2
14hypothetical protein93.20%0NC_027383.1
15hypothetical protein100%0YP_010741704.1
17hypothetical protein99.27%0NC_073079.1
18hypothetical protein 97.18%2.00 × 10−166NC_024783.1
20hypothetical protein89.34%8.00 × 10−146NC_016566.1
22hypothetical protein100%2.00 × 10−83YP_010741944.1
23hypothetical protein97.89%1.00 × 10−36NC_019724.1
30hypothetical protein100%0YP_010742349.1
31hypothetical protein97.26%2.00 × 10−44YP_010740694.1
32hypothetical protein83.85%8.00 × 10−146XEN42225.1
33hypothetical protein98.43%6.00 × 10−137YP_010742352.1
34hypothetical protein97.10%6.00 × 10−123YP_010741505.1
35hypothetical protein100%3.00 × 10−113YP_010741823.1
36hypothetical protein94.00%2.00 × 10−24YP_010740538.1
39hypothetical protein99.07%1.00 × 10−72YP_007112638.1
42hypothetical protein97.30%5.00 × 10−47YP_010741367.1
45hypothetical protein98.21%1.00 × 10−30YP_010740637.1
46hypothetical protein89.43%2.00 × 10−166YP_010741971.1
47hypothetical protein98.70%1.00 × 10−50WRQ05362.1
49hypothetical protein98.39%2.00 × 10−38YP_002720051.1
50hypothetical protein98.80%3.00 × 10−52YP_002720052.1
51hypothetical protein98.24%1.00 × 10−105YP_010742534.1
54hypothetical protein96.55%3.00 × 10−32YP_010741020.1
55hypothetical protein96.04%2.00 × 10−64XEC67447.1
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wan, S.; Li, N.; Habib, S.; Zheng, P.; Li, Y.; Liang, Y.; Qu, Y. Biological Characteristics and Whole-Genome Analysis of a Porcine E. coli Phage. Vet. Sci. 2025, 12, 57. https://doi.org/10.3390/vetsci12010057

AMA Style

Wan S, Li N, Habib S, Zheng P, Li Y, Liang Y, Qu Y. Biological Characteristics and Whole-Genome Analysis of a Porcine E. coli Phage. Veterinary Sciences. 2025; 12(1):57. https://doi.org/10.3390/vetsci12010057

Chicago/Turabian Style

Wan, Shenghui, Nana Li, Sajid Habib, Pei Zheng, Yanfang Li, Yan Liang, and Yonggang Qu. 2025. "Biological Characteristics and Whole-Genome Analysis of a Porcine E. coli Phage" Veterinary Sciences 12, no. 1: 57. https://doi.org/10.3390/vetsci12010057

APA Style

Wan, S., Li, N., Habib, S., Zheng, P., Li, Y., Liang, Y., & Qu, Y. (2025). Biological Characteristics and Whole-Genome Analysis of a Porcine E. coli Phage. Veterinary Sciences, 12(1), 57. https://doi.org/10.3390/vetsci12010057

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop